MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.940
+0.080
+2.80%
Closed 17:47 09/18 EDT
OPEN
2.840
PREV CLOSE
2.860
HIGH
2.980
LOW
2.820
VOLUME
360.87K
TURNOVER
--
52 WEEK HIGH
16.00
52 WEEK LOW
0.9310
MARKET CAP
12.57M
P/E (TTM)
-5.5211
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Marinus Pharmaceuticals, Plus Therapeutics among healthcare gainers, Nano-X Imaging, Vaxart lead losers
Gainers: Marinus Pharmaceuticals (MRNS) +83%, Plus Therapeutics (PSTV) +24%, Inovio Pharmaceuticals (INO) +21%, Arbutus Biopharma ABUS +15%, Bellicum Pharmaceuticals (BLCM) +15%.Losers: Nano-X Imaging (NNOX) -24%, Vaxart (VXRT) -14%, Cassava Sciences (SAVA) -14%, 89bio, Inc. (ETNB) -12%, Replimune Group, Inc. (REPL) -8%.
Seekingalpha · 5d ago
Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment
AUSTIN, Texas, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track designation for its lead investigational drug, Rhenium NanoLiposomes (RNL™), for the treatment
GlobeNewswire · 5d ago
Plus Therapeutics rallies on Fast Track status for glioblastoma treatment
Plus Therapeutics (PSTV) soars 41% premarket in reaction to Fast Track designation for lead investigational drug Rhenium NanoLiposomes ((RNL)) for the treatment of patients with recurrent glioblastoma, an aggressive type of cancer of the
Seekingalpha · 5d ago
Plus Therapeutics, Inc. to Present at the 22nd H. C. Wainwright Annual Global Investor Conference on September 15, 2020
AUSTIN, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has been invited to present at the 22nd H. C. Wainwright Annual Global Investment Conference, which is being held virtually on September 14-16, 2020. Plus Therapeutics, Inc
GlobeNewswire · 09/09 23:00
Plus Therapeutics, Inc. to Present at the 9th Annual Gateway Conference on September 10, 2020
AUSTIN, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has been invited to present at the 9th Annual Gateway Conference, which is being held virtually on September 9-10, 2020. Plus Therapeutics, Inc. management is scheduled to
GlobeNewswire · 09/03 11:00
GSX, HOME among premarket losers
ADiTx Therapeutics (ADTX) -16%.Jiayin Group (JFIN) -15% on Q2 earnings.At Home Group (HOME) -15% after strong Q2 results not enough following torrid rally.GSX Techedu (GSX) -14% on Q2 earnings.Plus Therapeutics (PSTV) -14%.Aptorum Group (APM) -9%.PEDEVCO (PED) -9%.Marathon
Seekingalpha · 09/02 12:10
Why Plus Therapeutics Stock Is Trading Higher Today
Plus Therapeutics (NASDAQ: PSTV) shares are trading higher Tuesday after the company announced the Food and Drug Administration has granted orphan drug designation for Rhenium NanoLiposomes for the treatment of patients with recurrent glioblastoma.
Benzinga · 09/01 15:41
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31)
Benzinga · 09/01 12:35
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PSTV stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 35
Institutional Holdings: 285.54K
% Owned: 6.68%
Shares Outstanding: 4.27M
TypeInstitutionsShares
Increased
2
2.93K
New
9
172
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.06%
Pharmaceuticals & Medical Research
+0.57%
Key Executives
Chairman/Director
Richard Hawkins
President
Steven Kesten
Chief Executive Officer/Director
Marc Hedrick
Chief Financial Officer/Vice President - Finance
Andrew Sims
Corporate Executive
Seijiro Shirahama
Senior Vice President
Gregory Stein
Chief Accounting Officer/Controller
Desiree Smith
Vice President - Business Development/General Counsel
Jeremy Hayden
Other
Mark Marino
Independent Director
Howard Clowes
Independent Director
Robert Lenk
Independent Director
Greg Petersen
Independent Director
Annigje van Es-Johansson
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average PSTV stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About PSTV
Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Plus Therapeutics Inc stock information, including NASDAQ:PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.